The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122328303 12232830 3 F 20151002 20160628 20160402 20160709 EXP JP-AMGEN-JPNCT2015139375 AMGEN 74.00 YR E M Y 0.00000 20160709 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122328303 12232830 1 PS panitumumab PANITUMUMAB 1 Intravenous drip 6 MG/KG, Q2WK 84 MG/KG N 125147 6 MG/KG SOLUTION FOR INJECTION QOW
122328303 12232830 2 SS panitumumab PANITUMUMAB 1 Intravenous drip 6 MG/KG, Q2WK 84 MG/KG N 125147 6 MG/KG SOLUTION FOR INJECTION QOW
122328303 12232830 3 SS panitumumab PANITUMUMAB 1 Intravenous drip 6 MG/KG, Q2WK 84 MG/KG N 125147 6 MG/KG SOLUTION FOR INJECTION QOW
122328303 12232830 4 SS panitumumab PANITUMUMAB 1 Intravenous drip 6 MG/KG, Q2WK 84 MG/KG N 125147 6 MG/KG SOLUTION FOR INJECTION QOW
122328303 12232830 5 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 400 MG/M2, Q2WK 42000 MG/M2 U 0 400 MG/M**2 QOW
122328303 12232830 6 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 2400 MG/M2, Q2WEEKS 42000 MG/M2 U 0 2400 MG/M**2 QOW
122328303 12232830 7 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 400 MG/M2, Q2WK 42000 MG/M2 U 0 400 MG/M**2 QOW
122328303 12232830 8 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 2400 MG/M2, Q2WEEKS 42000 MG/M2 U 0 2400 MG/M**2 QOW
122328303 12232830 9 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 400 MG/M2, Q2WK 42000 MG/M2 U 0 400 MG/M**2 QOW
122328303 12232830 10 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 2400 MG/M2, Q2WEEKS 42000 MG/M2 U 0 2400 MG/M**2 QOW
122328303 12232830 11 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 400 MG/M2, Q2WK 42000 MG/M2 U 0 400 MG/M**2 QOW
122328303 12232830 12 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 2400 MG/M2, Q2WEEKS 42000 MG/M2 U 0 2400 MG/M**2 QOW
122328303 12232830 13 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous bolus 400 MG/M2, Q2WK 42000 MG/M2 U 0 400 MG/M**2 QOW
122328303 12232830 14 SS 5-FU /00098801/ FLUOROURACIL 1 Intravenous drip 2400 MG/M2, Q2WEEKS 42000 MG/M2 U 0 2400 MG/M**2 QOW
122328303 12232830 15 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous drip 85 MG/M2, Q2WEEKS 510 MG/M2 U 0 85 MG/M**2 QOW
122328303 12232830 16 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 3000 MG/M2 U 0 200 MG/M**2 QOW
122328303 12232830 17 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 3000 MG/M2 U 0 200 MG/M**2 QOW
122328303 12232830 18 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 3000 MG/M2 U 0 200 MG/M**2 QOW
122328303 12232830 19 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 3000 MG/M2 U 0 200 MG/M**2 QOW
122328303 12232830 20 C CALCIUM LEVOFOLINATE LEVOLEUCOVORIN CALCIUM 1 Intravenous drip 200 MG/M2, Q2WEEKS 3000 MG/M2 U 0 200 MG/M**2 QOW

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122328303 12232830 1 Colon cancer
122328303 12232830 5 Colon cancer
122328303 12232830 15 Colon cancer
122328303 12232830 16 Colon cancer

Outcome of event

Event ID CASEID OUTC COD
122328303 12232830 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
122328303 12232830 Amylase increased
122328303 12232830 Dermatitis acneiform
122328303 12232830 Paronychia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122328303 12232830 1 20150428 20150721 0
122328303 12232830 2 20150811 20150908 0
122328303 12232830 3 20151013 20151124 0
122328303 12232830 4 20160202 20160202 0
122328303 12232830 5 20150428 20150721 0
122328303 12232830 6 20150428 20150721 0
122328303 12232830 7 20150811 20150908 0
122328303 12232830 8 20150811 20150908 0
122328303 12232830 9 20151013 20151110 0
122328303 12232830 10 20151013 20151110 0
122328303 12232830 11 20151208 20151222 0
122328303 12232830 12 20151208 20151222 0
122328303 12232830 13 20160202 20160202 0
122328303 12232830 14 20160202 20160202 0
122328303 12232830 15 20150428 20150707 0
122328303 12232830 16 20150428 20150721 0
122328303 12232830 17 20150811 20150908 0
122328303 12232830 18 20151013 20151110 0
122328303 12232830 19 20151208 20151222 0
122328303 12232830 20 20160202 20160202 0

Execution Time: 0.0085699558258057 seconds (ucode:5205082). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.